Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) Operating Income (2023 - 2026)

Adagio Medical Holdings has reported Operating Income over the past 4 years, most recently at -$5.2 million for Q1 2026.

  • Quarterly Operating Income rose 29.7% to -$5.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$19.6 million through Mar 2026, up 28.17% year-over-year, with the annual reading at -$21.9 million for FY2025, 64.96% up from the prior year.
  • Operating Income was -$5.2 million for Q1 2026 at Adagio Medical Holdings, down from -$4.0 million in the prior quarter.
  • Over five years, Operating Income peaked at -$4.0 million in Q4 2025 and troughed at -$9.1 million in Q3 2023.
  • The 4-year median for Operating Income is -$5.5 million (2023), against an average of -$6.1 million.
  • Year-over-year, Operating Income skyrocketed 51.27% in 2024 and then dropped 29.29% in 2025.
  • A 4-year view of Operating Income shows it stood at -$5.3 million in 2023, then grew by 17.03% to -$4.4 million in 2024, then rose by 10.33% to -$4.0 million in 2025, then crashed by 31.05% to -$5.2 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Operating Income are -$5.2 million (Q1 2026), -$4.0 million (Q4 2025), and -$5.7 million (Q3 2025).